Show simple item record

dc.contributor.authorUyar, Yavuz
dc.contributor.authorZeller, Herve
dc.contributor.authorWeber, Friedemann
dc.contributor.authorSwanepoel, Robert
dc.contributor.authorNeyts, Johan
dc.contributor.authorNiedrig, Matthias
dc.contributor.authorÖZKUL, AYKUT
dc.contributor.authorPapa, Anna
dc.contributor.authorWeidmann, Manfred
dc.contributor.authorAvsic-Zupanc, Tatjana
dc.contributor.authorBino, Silvia
dc.contributor.authorBouloy, Michelle
dc.contributor.authorBurt, Felicity
dc.contributor.authorChinikar, Sadegh
dc.contributor.authorChristova, Iva
dc.contributor.authorDedushaj, Isuf
dc.contributor.authorSchmaljohn, Connie S.
dc.contributor.authorSall, Amadou A.
dc.contributor.authorPaweska, Janusz
dc.contributor.authorEl-Sanousi, Ahmed
dc.contributor.authorELALDI, NAZİF
dc.contributor.authorHewson, Roger
dc.contributor.authorHufert, Frank T.
dc.contributor.authorHumolli, Isme
dc.contributor.authorvan Vuren, Petrus Jansen
dc.contributor.authorTufan, Zeliha Kocak
dc.contributor.authorKorukluoglu, Gulay
dc.contributor.authorLyssen, Pieter
dc.contributor.authorMirazimi, Ali
dc.date.accessioned2021-03-03T15:28:38Z
dc.date.available2021-03-03T15:28:38Z
dc.identifier.citationWeidmann M., Avsic-Zupanc T., Bino S., Bouloy M., Burt F., Chinikar S., Christova I., Dedushaj I., El-Sanousi A., ELALDI N., et al., "Biosafety standards for working with Crimean-Congo hemorrhagic fever virus", JOURNAL OF GENERAL VIROLOGY, cilt.97, ss.2799-2808, 2016
dc.identifier.issn0022-1317
dc.identifier.otherav_3f3366b1-8f3a-4446-8765-f904955c0246
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/46295
dc.identifier.urihttps://doi.org/10.1099/jgv.0.000610
dc.description.abstractIn countries from which Crimean-Congo haemorrhagic fever (CCHF) is absent, the causative virus, CCHF virus (CCHFV), is classified as a hazard group 4 agent and handled in containment level (CL)-4. In contrast, most endemic countries out of necessity have had to perform diagnostic tests under biosafety level (BSL)-2 or -3 conditions. In particular, Turkey and several of the Balkan countries have safely processed more than 100 000 samples over many years in BSL-2 laboratories. It is therefore advocated that biosafety requirements for CCHF diagnostic procedures should be revised, to allow the tests required to be performed under enhanced BSL-2 conditions with appropriate biosafety laboratory equipment and personal protective equipment used according to standardized protocols in the countries affected. Downgrading of CCHFV research work from CL-4, BSL-4 to CL-3, BSL-3 should also be considered.
dc.language.isoeng
dc.subjectBİYOTEKNOLOJİ VE UYGULAMALI MİKROBİYOLOJİ
dc.subjectMikrobiyoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectVİROLOJİ
dc.subjectİmmünoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectMikrobiyoloji ve Klinik Mikrobiyoloji
dc.subjectViroloji
dc.subjectYaşam Bilimleri
dc.subjectBiyoteknoloji
dc.subjectTemel Bilimler
dc.titleBiosafety standards for working with Crimean-Congo hemorrhagic fever virus
dc.typeMakale
dc.relation.journalJOURNAL OF GENERAL VIROLOGY
dc.contributor.departmentUniversity Of Stirling , ,
dc.identifier.volume97
dc.identifier.startpage2799
dc.identifier.endpage2808
dc.contributor.firstauthorID236938


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record